USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Helmholtz-zentrum Für Infektionsforschung Gmbh

USPTO PatentsView assignee record - 26 granted patents across 16 technology areas, recorded in grant years 2015–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES).

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

11.1

Avg claims per patent

-14%

5-year grant velocity

The verdict

According to USPTO PatentsView, Helmholtz-zentrum ranks #11,667 of 50,000 tracked US assignees by granted-patent volume, with 26 patents across 16 technology areas.

#11,667
of 50,000 US assignees by volume: Top 46%
by Innovation Score (36.6/100): 11.1
avg claims per patent: -14%
grant velocity, last 5 yrs

Portfolio overview

Helmholtz-zentrum Für Infektionsforschung Gmbh has been granted 26 US utility patents between 2015 and 2024, placing Helmholtz-zentrum Für Infektionsforschung Gmbh at #11,667 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 16 distinct Cooperative Patent Classification (CPC) subclasses, averaging 11.1 claims per patent with primary concentration in A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES). As a Foreign Corporation, Helmholtz-zentrum Für Infektionsforschung Gmbh is one of the more focused assignees in the PatentsView dataset. By volume, Helmholtz-zentrum sits between Horiba ABX SAS (26 patents, rank #11,666) and IDTP Holdings, Inc. (26 patents, rank #11,674) - the closest US assignees by grant volume. The composite Innovation Score of 36.6/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 12 grants, compared with 14 in the 2015–2019 window, a -14% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Helmholtz-zentrum Für Infektionsforschung Gmbh's 11.1 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 16 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Horiba ABX SAS

26
Husky

26
Hangzhou Glority…

26
Healgen Scientific

26
Hikma Pharmaceuti…

26
Hubei University

26
Humancentric Vent…

26
IDTP Holdings

26
Helmholtz-zentrum… ◀

26

What this shows Helmholtz-zentrum holds 26 patents at rank #11,670, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Helmholtz-zentrum

By rank, the assignees closest to #11,670 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Helmholtz-zentrum's primary technology class.

Helmholtz-zentrum's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 46% higher than 54% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Helmholtz-zentrum Für Infektionsforschung Gmbh patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	11.5%
2016	2	7.7%
2017	1	3.8%
2019	8	30.8%
2020	1	3.8%
2021	3	11.5%
2022	6	23.1%
2023	1	3.8%
2024	1	3.8%

Which technologies does Helmholtz-zentrum Für Infektionsforschung Gmbh patent most?

A61K - PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES 21

A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 20

C07K - PEPTIDES 8

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 8

Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE 8

C07D - HETEROCYCLIC COMPOUNDS 8

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 6

C07C - ACYCLIC OR CARBOCYCLIC COMPOUNDS 5

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 3

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 3

C12Y - ENZYMES 2

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 2

A61M - DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY ; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY ; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR 2

C07H - SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 2

C12R - INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS 1

Top 15 of 16 technology areas

Grant record at a glance

Portfolio Volume 26 grants

CPC subclasses 16

Avg. claims / grant 11.1

Velocity -14%

Historical grant data only; it does not rate legal strength or current strategy.

Where it ranks

Overall rank by patents

#11,667

of 50,000 tracked assignees

Innovation Score

36.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

Where does Helmholtz-zentrum Für Infektionsforschung Gmbh rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Helmholtz-zentrum Für Infektionsforschung Gmbh ranks #11,667 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Helmholtz-zentrum Für Infektionsforschung Gmbh hold?

Helmholtz-zentrum Für Infektionsforschung Gmbh holds 26 US utility patents granted between 2015 and 2024, spanning 16 technology areas.

What is Helmholtz-zentrum Für Infektionsforschung Gmbh's Innovation Score?

Helmholtz-zentrum Für Infektionsforschung Gmbh has an Innovation Score of 36.6 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Helmholtz-zentrum Für Infektionsforschung Gmbh focus on?

Helmholtz-zentrum Für Infektionsforschung Gmbh's top technology area is A61K (PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES) with 21 patents. Grants appear in 16 CPC subclasses total.

Is Helmholtz-zentrum Für Infektionsforschung Gmbh's patent grant rate increasing or decreasing?

Helmholtz-zentrum Für Infektionsforschung Gmbh's recent grant velocity is -14% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Helmholtz-zentrum Für Infektionsforschung Gmbh's patents?

Helmholtz-zentrum Für Infektionsforschung Gmbh's patents average 11.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Helmholtz-zentrum Für Infektionsforschung Gmbh patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Helmholtz-zentrum's 26 grants land it in the top 46% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Helmholtz-zentrum ranks #11,667 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61K - see who else leads that technology area. A61K leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Cite this page

Plainpatent, “Helmholtz-zentrum Für Infektionsforschung Gmbh Patent Portfolio.” Compiled from the underlying federal/official data source; data as of 2015–2025. https://plainpatent.com/company/helmholtz-zentrum-f%C3%BCr-infektionsforschung-gmbh/

Formal citation formats (APA / MLA)

APA: Plainpatent. (2015). Helmholtz-zentrum Für Infektionsforschung Gmbh Patent Portfolio. Retrieved August 15, 2026, from https://plainpatent.com/company/helmholtz-zentrum-f%C3%BCr-infektionsforschung-gmbh/

MLA: "Helmholtz-zentrum Für Infektionsforschung Gmbh Patent Portfolio." Plainpatent, 2015, https://plainpatent.com/company/helmholtz-zentrum-f%C3%BCr-infektionsforschung-gmbh/.

You are welcome to quote these figures with attribution to Plainpatent and the underlying source. The URL above is stable. Licensed CC BY 4.0 - reuse with attribution.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.